Sangamo Biosciences, Inc. (SGMO) Reports In-Line Q4 EPS Loss of $0.12
SGMO Hot Sheet
EPS Growth %: +33.3%Financial Fact:
Research grants: 1.58M
Today's EPS Names:
TARO, BRLI, TLB, More
Sangamo Biosciences, Inc. (NASDAQ: SGMO) reported Q4 EPS of ($0.12), in-line with the analyst estimate of ($0.12). Revenue for the quarter came in at $4.7 million versus the consensus estimate of $3.41 million.
Sangamo Biosciences, Inc. sees FY2012 revenue of $14-$18 million, versus the consensus of $16.23 million.
For earnings history and earnings-related data on Sangamo Biosciences, Inc. (SGMO) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Sangamo Biosciences, Inc. sees FY2012 revenue of $14-$18 million, versus the consensus of $16.23 million.
For earnings history and earnings-related data on Sangamo Biosciences, Inc. (SGMO) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Mentor Graphics Corp (MENT) Beats Q1 EPS View by 5c; Lifts FY13 Outlook
- Synopsys, Inc. (SNPS) Misses Q2 EPS by 2c; Issues Confident Q3 Outlook; Guides FY12
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
